Annual CFF:
$255.87M-$390.53M(-60.42%)Summary
- As of today, PTCT annual cash from financing is $255.87 million, with the most recent change of -$390.53 million (-60.42%) on December 31, 2024.
- During the last 3 years, PTCT annual cash from financing has risen by +$234.99 million (+1125.59%).
- PTCT annual cash from financing is now -61.74% below its all-time high of $668.72 million, reached on December 31, 2020.
Performance
PTCT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$3.96M-$5.45M(-57.91%)Summary
- As of today, PTCT quarterly cash from financing is $3.96 million, with the most recent change of -$5.45 million (-57.91%) on June 30, 2025.
- Over the past year, PTCT quarterly cash from financing has dropped by -$242.52 million (-98.39%).
- PTCT quarterly cash from financing is now -99.38% below its all-time high of $643.05 million, reached on September 30, 2020.
Performance
PTCT Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$22.21M-$242.52M(-91.61%)Summary
- As of today, PTCT TTM cash from financing is $22.21 million, with the most recent change of -$242.52 million (-91.61%) on June 30, 2025.
- Over the past year, PTCT TTM cash from financing has dropped by -$848.65 million (-97.45%).
- PTCT TTM cash from financing is now -97.45% below its all-time high of $870.87 million, reached on June 30, 2024.
Performance
PTCT TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PTCT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -60.4% | -98.4% | -97.5% |
| 3Y3 Years | +1125.6% | +2.6% | +79.8% |
| 5Y5 Years | -58.3% | +112.0% | -96.5% |
PTCT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -60.4% | +1125.6% | -99.4% | +102.8% | -97.5% | +117.0% |
| 5Y | 5-Year | -61.7% | +1125.6% | -99.4% | +102.8% | -97.5% | +117.0% |
| All-Time | All-Time | -61.7% | +3663.7% | -99.4% | +102.8% | -97.5% | +117.0% |
PTCT Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $3.96M(-57.9%) | $22.21M(-91.6%) |
| Mar 2025 | - | $9.41M(-64.5%) | $264.74M(+3.5%) |
| Dec 2024 | $255.87M(-60.4%) | $26.47M(+250.2%) | $255.87M(-69.9%) |
| Sep 2024 | - | -$17.63M(-107.2%) | $849.88M(-2.4%) |
| Jun 2024 | - | $246.48M(>+9900.0%) | $870.87M(+35.5%) |
| Mar 2024 | - | $540.00K(-99.9%) | $642.85M(-0.5%) |
| Dec 2023 | $646.40M(+284.9%) | $620.49M(>+9900.0%) | $646.40M(+96.6%) |
| Sep 2023 | - | $3.36M(-81.8%) | $328.83M(+77.3%) |
| Jun 2023 | - | $18.46M(+350.9%) | $185.48M(+8.5%) |
| Mar 2023 | - | $4.09M(-98.6%) | $170.88M(+1.7%) |
| Dec 2022 | $167.95M(+704.5%) | $302.92M(+316.4%) | $167.95M(+228.6%) |
| Sep 2022 | - | -$140.00M(-3725.9%) | -$130.61M(-1156.8%) |
| Jun 2022 | - | $3.86M(+230.6%) | $12.36M(-1.2%) |
| Mar 2022 | - | $1.17M(-73.2%) | $12.51M(-40.1%) |
| Dec 2021 | $20.88M(-96.9%) | $4.35M(+46.3%) | $20.88M(-63.1%) |
| Sep 2021 | - | $2.98M(-25.9%) | $56.61M(-91.9%) |
| Jun 2021 | - | $4.02M(-57.9%) | $696.69M(+5.6%) |
| Mar 2021 | - | $9.53M(-76.2%) | $659.76M(-1.3%) |
| Dec 2020 | $668.72M(+9.1%) | $40.09M(-93.8%) | $668.72M(+6.0%) |
| Sep 2020 | - | $643.05M(+2053.5%) | $630.91M(+70.4%) |
| Jun 2020 | - | -$32.92M(-278.0%) | $370.21M(-8.8%) |
| Mar 2020 | - | $18.49M(+709.5%) | $405.98M(-33.8%) |
| Dec 2019 | $613.21M(+366.1%) | $2.28M(-99.4%) | $613.21M(-0.2%) |
| Sep 2019 | - | $382.35M(>+9900.0%) | $614.65M(+158.9%) |
| Jun 2019 | - | $2.85M(-98.7%) | $237.38M(-33.4%) |
| Mar 2019 | - | $225.72M(+5958.0%) | $356.16M(+170.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $131.57M(+197.6%) | $3.73M(-26.7%) | $131.57M(+1.4%) |
| Sep 2018 | - | $5.08M(-95.8%) | $129.70M(+2.7%) |
| Jun 2018 | - | $121.63M(>+9900.0%) | $126.32M(+182.7%) |
| Mar 2018 | - | $1.14M(-38.6%) | $44.69M(+1.1%) |
| Dec 2017 | $44.22M(+4468.0%) | $1.85M(+8.4%) | $44.22M(+4.3%) |
| Sep 2017 | - | $1.71M(-95.7%) | $42.41M(+2.0%) |
| Jun 2017 | - | $40.00M(+5932.7%) | $41.59M(+2504.5%) |
| Mar 2017 | - | $663.00K(+1478.6%) | $1.60M(+65.0%) |
| Dec 2016 | $968.00K(-99.4%) | $42.00K(-95.3%) | $968.00K(+2.1%) |
| Sep 2016 | - | $892.00K(>+9900.0%) | $948.00K(-99.4%) |
| Jun 2016 | - | $0.00(-100.0%) | $146.02M(-3.3%) |
| Mar 2016 | - | $34.00K(+54.5%) | $151.08M(-1.9%) |
| Dec 2015 | $154.06M(-35.0%) | $22.00K(-100.0%) | $154.06M(-43.5%) |
| Sep 2015 | - | $145.97M(+2788.7%) | $272.44M(+114.8%) |
| Jun 2015 | - | $5.05M(+67.4%) | $126.83M(+4.0%) |
| Mar 2015 | - | $3.02M(-97.5%) | $122.00M(-48.6%) |
| Dec 2014 | $237.13M(+26.5%) | $118.40M(>+9900.0%) | $237.13M(+99.8%) |
| Sep 2014 | - | $359.00K(+64.7%) | $118.69M(+2.8%) |
| Jun 2014 | - | $218.00K(-99.8%) | $115.47M(-53.8%) |
| Mar 2014 | - | $118.15M(>+9900.0%) | $250.20M(+33.5%) |
| Dec 2013 | $187.44M(+736.4%) | -$36.00K(+98.7%) | $187.44M(+0.4%) |
| Sep 2013 | - | -$2.86M(-102.1%) | $186.77M(-1.5%) |
| Jun 2013 | - | $134.94M(+143.6%) | $189.63M(+246.8%) |
| Mar 2013 | - | $55.39M(+7972.2%) | $54.69M(+1902.4%) |
| Dec 2012 | $22.41M(+412.1%) | -$703.60K(+69.8%) | -$3.03M(-30.2%) |
| Mar 2012 | - | -$2.33M | -$2.33M |
| Dec 2011 | -$7.18M | - | - |
FAQ
- What is PTC Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual cash from financing year-on-year change?
- What is PTC Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is PTC Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. TTM cash from financing year-on-year change?
What is PTC Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of PTCT is $255.87M
What is the all-time high annual cash from financing for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual cash from financing is $668.72M
What is PTC Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, PTCT annual cash from financing has changed by -$390.53M (-60.42%)
What is PTC Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of PTCT is $3.96M
What is the all-time high quarterly cash from financing for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly cash from financing is $643.05M
What is PTC Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, PTCT quarterly cash from financing has changed by -$242.52M (-98.39%)
What is PTC Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of PTCT is $22.21M
What is the all-time high TTM cash from financing for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high TTM cash from financing is $870.87M
What is PTC Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, PTCT TTM cash from financing has changed by -$848.65M (-97.45%)